Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 23, 2025, Pharnext SCA (ALPHA.PA) has a market cap of $2,751 Dollars USD. According to our data, Pharnext SCA is ranked No.9325 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 23, 2025 | $2,751 Dollars |
-0.00%
|
| Dec 31, 2024 | $0.00 M |
-99.00%
|
| Dec 29, 2023 | $0.28 M |
-100.00%
|
| Dec 30, 2022 | $185.70 B |
-85.00%
|
| Dec 31, 2021 | $1.238 T |
-94.55%
|
| Dec 31, 2020 | $22.696 T |
-41.70%
|
| Dec 31, 2019 | $38.927 T |
-46.10%
|
| Dec 31, 2018 | $72.215 T |
31.25%
|
| Dec 29, 2017 | $55.021 T |
-13.51%
|
| Dec 30, 2016 | $63.618 T |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
 Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
 Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
 GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
 AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
 Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
 Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
 Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
 Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
 AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
| Market Cap | = | ALPHA.PA Stock Price | * | ALPHA.PA Shares Outstanding |
| = | $0.00 | * | 13.21 M | |
| = | $2,751 Dollars |